膜性BCS行PTA术后的随访研究  

Follow up Study of Membranous Budd-Chiari Syndrome Treated By Percutaneous Transluminal Angioplasty

作　　者：夏进东[1] 黄菊芬[2] 王玲[2] 邹建华[1] 

机构地区：[1]湖北省十堰市太和医院放射科,湖北十堰442000 [2]湖北省十堰市太和医院B超室,湖北十堰442000

出　　处：《实用放射学杂志》2001年第9期672-673,共2页Journal of Practical Radiology

摘　　要：目的　膜性BCS行PTA术后长期随访 ,观察其疗效和并发症。方法　 18例膜性BCS行PTA术后患者有较完整的随访资料 ,随访时间 :>8年 4例 ,5 8年 8例 ,35年 3例 ,13年 2例 ,<1年 1例。门诊随访行彩超检查 12例 ,电话或信访 6例。结果　 18例患者术后 2 7d临床症状及体征减轻或消失 ,88.9% ( 16/18)的病人能从事体力劳动。 2例在术后即分别出现肺梗塞及心力衰竭 ,1例术后 1年出现再狭窄。结论　膜性BCS患者PTA治疗应是首选方法 ,术前术后抗凝药物的应用及术中球囊充分扩张破膜是预防再狭窄及血栓形成的主要方法。Objective To study the long term result of membranous Budd-Chiari syndrome after percutaneous transluminal angioplasty(PTA)treatment.Methods 18 patients with membranous BCS were followed up for 1~8 years after PTA.Follow up time was:>8 years for 4 cases;5~8 years for 8 cases;3~5 years for 3 cases;less than 1 year for 1 case respectively.12 cases were followed up by color-sonography examination.The remaining 6 cases were followed by mail or phonecall.Results All cases reached clinical cure with relief or diasppearance of relevant symptoms and signs after 2~7 days PTA.88.9%(16/18) of the cases regained obility to labour or return to work.2 cases of the patients had lung infarction and heart failure immediately after the treatment,1 patient had recurrent stenosis and thrombosis after 1 year of PTA.Conclusion For treatment of membranous BCS,PTA should be the first choice.The majority methods of preventing recurrent stenosis and thrombosis are antithrombin application before PTA and adequate angioplasty during PTA.

关 键 词：腔静脉 经皮血管成形术 介入性放射学 PTA术 膜性BCS 布-加综合征 

分 类 号：R657.34[医药卫生—外科学]